IP Library › Granted Patent US 10,376,489
Granted Patent B2
US 10,376,489 · App. 15/492,649 · Granted Aug 13, 2019

Wound healing

Inventors: Manuela Martins-Green (Riverside, CA); Sandeep Dhall (Elkridge, MD); Danh Do (Baltimore, MD); Neal Schiller (Riverside, CA)
Assignee: The Regents of the University of California
A61K31/355A61K31/198A61K45/06A61L15/44A61L26/0066A61L2300/412
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,376,489
App. No.
15/492,649
Granted
Aug 13, 2019
Kind
B2
Abstract

A method of treating a chronic wound in a subject in need of such treatment is provided. The method includes administering to the subject at least one antioxidant agent in an amount effective to treat the wound. In some versions, the antioxidant agent is α-tocopherol or N-acetyl cysteine, or a combination of these compounds. In other versions, a method of preparing a chronic wound animal model is provided.

Claims (20)

1. A method of treating a mouse to cause it to have a chronic wound whereby the mouse can be used as an animal model, comprising

creating a fresh wound in a mouse,

inhibiting at least two antioxidant agents located within the fresh wound, and

allowing the fresh wound to develop into a chronic wound,

wherein the inhibiting is performed by administering to the mouse one or more inhibitors of the at least one antioxidant agent, where the one or more inhibitors is an inhibitor of catalase, an inhibitor of glutathione peroxidase, or a combination thereof.

2. A chronic wound animal model prepared by the method of claim 1 .

3. A method of screening for an agent that treats chronic wounds, comprising screening a compound for its ability to reduce or heal a chronic wound of an animal model, wherein the animal model results from treating a mouse to cause it to have a chronic wound whereby the mouse can be used as an animal model, comprising:

creating a fresh wound in a mouse,

inhibiting at least two antioxidant agents located within the fresh wound, and

allowing the fresh wound to develop into the chronic wound,

wherein the inhibiting is performed by administering to the mouse one or more inhibitors of the at least one antioxidant agent, where the one or more inhibitors is an inhibitor of catalase, an inhibitor of glutathione peroxidase, or a combination thereof.

4. The method of claim 3 , wherein the mouse is a db/db mouse.

5. The method of claim 3 , wherein the at least one antioxidant agent is a free radical scavenger, a lipid peroxidation inhibitor, or a combination thereof.

6. The method of claim 3 , wherein the at least one antioxidant agent is catalase, glutathione peroxidase, or a combination thereof.

7. The method of claim 3 , wherein the one or more inhibitors is mercaptosuccinic acid, 3-amino-1,2,4-triazole, or a combination thereof.

8. The method of claim 3 , wherein the administering is performed before creating the fresh wound or after creating the fresh wound.

9. The method of claim 3 , wherein the administering is performed before and after creating the fresh wound.

10. The method of claim 3 , wherein the chronic wound comprises a biofilm.

11. The method of claim 3 , wherein the allowing comprises covering the fresh wound with a dressing to prevent contamination.

12. The method of claim 1 , wherein the one or more inhibitors is mercaptosuccinic acid, 3-amino-1,2,4-triazole, or a combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2017
From: MARTINS-GREEN, MANUELA; DHALL, SANDEEP; DO, DANH; SCHILLER, NEAL
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 042084/0322 →
Continuity (3)
Continuation 15162570 · May 23, 2016
Provisional Application 62165156 · May 21, 2015
Related Publication 20170252320A1 · Sep 7, 2017